Journal of Neuroimmunology
Volume 221, Issue 1 , Pages 32-41 , 15 April 2010

The hypothalamic endocannabinoid system participates in the secretion of oxytocin and tumor necrosis factor-alpha induced by lipopolysaccharide

Received 12 January 2010 ,Revised 4 February 2010 ,Accepted 4 February 2010.

References 

  1. Antunes-Rodrigues J, De Castro M, Elias L, Valenca M, McCann SM. Neuroendocrine control of body fluid metabolism. Physiol. Rev. 2004;84:169–208
  2. Besedovsky H, Del Rey A. Immune-neuroendocrine interactions: facts and hypotheses. Endocr. Rev. 1996;17:64–102
  3. Bredt DS, Snyder SH. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc. Natl Acad. Sci. U.S.A. 1989;86:9030–9033
  4. Caruso C, Durand D, Schiöth HB, Rey R, Seilicovich A, Lasaga M. Activation of melanocortin 4 receptors reduces the inflammatory response and prevents apoptosis induced by lipopolysaccharide and interferon-gamma in astrocytes. Endocrinology. 2007;148(10):4918–4926
  5. Cristino L, de Petrocellis L, Pryce G, Baker D, Guglielmotti V, Di Marzo V. Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain. Neuroscience. 2006;139(4):1405–1415
  6. Croci T, Landi M, Galzin AM, Marini P. Role of cannabinoid CB1 receptors and tumor necrosis factor-alpha in the gut and systemic anti-inflammatory activity of SR 141716 (rimonabant) in rodents. Br. J. Pharmacol. 2003;140(1):115–122
  7. De Laurentiis A, Pisera D, Duvilanski B, Rettori V, Lasaga M, Seilicovich A. Neurokinin A inhibits oxytocin and GABA release from GABA release from the posterior pituitary by stimulating nitric oxide synthase. Brain Res. Bull. 2000;53:325–330
  8. Di Marzo V, Bisogno T, De Petrocellis L, Melck D, Orlando P, Wagner JA, et al. Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages. Eur. J. Biochem. 1999;264(1):258–267
  9. Di S, Malcher-Lopes R, Marcheselli VL, Bazan NG, Tasker JG. Rapid glucocorticoid-mediated endocannabinoid release and opposing regulation of glutamate and GABA inputs to hypothalamic magnocellular neurons. Endocrinology. 2005;146:4292–4301
  10. Di S, Boudaba C, Popescu IR, Weng F, Harris C, Marcheselli VL, et al. Activity-dependent release and actions of endocannabinoids in the rat hypothalamic supraoptic nucleus. J. Physiol. 2005;569:751–760
  11. Dunn AJ. Role of cytokines in infection-induced stress. Ann. N.Y. Acad. Sci. 1993;697:189–202
  12. Elias LL, Antunes-Rodrigues J, Elias PC, Moreira AC. Effect of plasma osmolality on pituitary–adrenal responses to corticotropin-releasing hormone and atrial natriuretic peptide changes in central diabetes insipidus. J. Clin. Endocrinol. Metab. 1997;82(4):1243–1247
  13. Fernandez-Solari J, Prestifilippo JP, Bornstein SR, McCann SM, Rettori V. Participation of the endocannabinoid system in the effect of TNF-alpha on hypothalamic release of gonadotropin-releasing hormone. Ann. N.Y. Acad. Sci. 2006;1088:238–250
  14. Fezza F, De Simone C, Amadio D, Maccarrone M. Fatty acid amide hydrolase: a gate-keeper of the endocannabinoid system. Subcell. Biochem. 2008;49:101–132
  15. Freund T, Katona I, Piomelli D. Role of endogenous cannabinoids in synaptic signalling. Physiol. Rev. 2003;83:1017–1066
  16. Gimpl G, Farhrenholz F. The oxytocin receptor system: structure, function and regulation. Physiol. Rev. 2001;81(2):629–683
  17. Giusti Paiva A, Kagohara Elías LL, Antunes-Rodriguez J. Inhibitory effect of gaseous neuromodulators in vasopressin and oxytocin release induced by endotoxin in rats. Neurosci. Lett. 2005;381:320–324
  18. Giusti Paiva A, Ruginsk SG, de Castro M, Kagohara Elías LL, Carnio EC, Antunes-Rodriguez J. Role of nitric oxide in lipopolysaccharide-induced release of vasopressin in rats. Neurosci. Lett. 2003;346:21–24
  19. Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC. Characterization and localization of cannabiniod receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci. 1991;11:563–583
  20. Howlet A, Breivogel C, Childers S, Deadwyler S, Hampson R, Porrino L. Cannabinoid physiology and pharmacology: 30years of progress. Neuropharmacology. 2004;47:345–358
  21. Kadekaro M. Nitric oxide modulation of the hypothalamo-neurohypophyseal system. Braz. J. Med. Biol. Res. 2004;37:441–450
  22. Kasting NW. Characteristics of body temperature, vasopressin, and oxytocin responses to endotoxin in the rat. Can. J. Physiol. Pharmacol. 1986;64(12):1575–1578
  23. Leng G, Ludwig M. Neurotransmitters and peptides: whispered secrets and public announcements. J. Physiol. 2008;586(Pt 23):5625–5632
  24. Leng G, Brown CH, Russell JA. Physiological pathways regulating the activity of magnocellular neurosecretory cells. Prog. Neurobiol. 1999;57(6):625–655
  25. Maccarrone M, De Petrocellis L, Bari M, Fezza F, Salvati S, Di Marzo V, et al. Lipopolysaccharide downregulates fatty acid amide hydrolase expression and increases anandamide levels in human peripheral lymphocytes. Arch. Biochem. Biophys. 2001;393(2):321–328
  26. Maccarrone M, Falciglia K, Di Rienzo M, Finazzi-Agrò A. Endocannabinoids, hormone-cytokine networks and human fertility. Prostaglandins Leukot. Essent. Fatty Acids. 2002;66(2–3):309–317
  27. Mastronardi CA, Yu WH, McCann SM. Lipopolysaccharide-induced tumor necrosis factor-alpha release is controlled by the central nervous system. Neuroimmunomodulation. 2001;9:148–156
  28. Matsunaga W, Miyata S, Takamata A, Bun H, Nakashima T, Kiyohara T. LPS-induced Fos expression in oxytocin and vasopressin neurons of the rat hypothalamus. Brain Res. 2000;858(1):9–18
  29. McCann SM, Karanth S, Kamat A, Les Dees W, Lyson K, Gimeno M, et al. Induction by cytokines of the pattern of pituitary hormone secretion in infection. Neuroimmunomodulation. 1994;1(1):2–13
  30. McCann SM, Antunes-Rodrigues J, Franci CR, Anselmo-Franci JA, Karanth S, Rettori V. Role of the hypothalamic pituitary adrenal axis in the control of the response to stress and infection. Braz. J. Med. Biol. Res. 2000;33(10):1121–1131
  31. McCann SM, Kimura M, Karanth S, Yu WH, Mastronardi CA, Rettori V. The mechanism of action of cytokines to control the release of hypothalamic and pituitary hormones in infection. Ann. N.Y. Acad. Sci. 2000;917:4–18
  32. McCann SM, Mastronardi C, De Laurentiis A, Rettori V. The nitric oxide theory of aging revisited. Ann. N.Y. Acad. Sci. 2005;1057:64–84
  33. McDonald NA, Kuzmiski JB, Naderi N, Schwab Y, Pittman QJ. Endogenous modulators of synaptic transmission: cannabinoid regulation in the supraopitc nucleus. In:  Neumann ID,  Landgraf R editor. Progress in Brain Research. vol. 170:Oxford, UK: Elsevier; 2008;p. 129–136
  34. Molina-Holgado F, Molina-Holgado E, Guaza C. The endogenous cannabinoid anandamide potentiates interleukin-6 production by astrocytes infected with Theiler's murine encephalomyelitis virus by a receptor-mediated pathway. FEBS Lett. 1998;433(1–2):139–142
  35. Murphy LL, Muñoz RM, Adrian BA, Villanúa MA. Function of cannabinoid receptors in the neuroendocrine regulation of hormone secretion. Neurobiol. Dis. 1998;5:432–436
  36. Oliet SH, Baimoukhametova DV, Piet R, Bains JS. Retrograde regulation of GABA transmission by the tonic release of oxytocin and endocannabinoids governs postsynaptic firing. J Neurosci. 2007;27(6):1325–1333
  37. Pagotto U, Marsicano G, Cota D, Lutz B, Pasquali R. The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endocr. Rev. 2006;27(1):73–100
  38. Pellegrino LJ, Pellegrino AS, Ashman AJ. A Stereotaxic Atlas of the Rat Brain. 2nd ed.. New York: Plenum Press; 1979;
  39. Pertwee RG. The pharmacology of cannabinoid receptors and their ligands: an overview. Int. J. Obes. 2006;30:S13–S18
  40. Rettori V, Canteros G, Reynoso R, Gimeno M, McCann SM. Oxytocin stimulates the release of luteinizing hormone-releasing hormone from medial basal hypothalamic explants by releasing nitric oxide. Proc. Natl. Acad. Sci. 1997;94:2741–2744
  41. Rettori V, Fernandez-Solari J, Mohn C, Zorrilla Zubilete MA, de la Cal C, Prestifilippo JP, et al. Nitric oxide at the crossroad of immunoneuroendocrine interactions. Ann. N.Y. Acad. Sci. 2009;1153:35–47
  42. Roche M, Diamond M, Kelly JP, Finn DP. In vivo modulation of LPS-induced alterations in brain and peripheral cytokines and HPA axis activity by cannabinoids. J. Neuroimmunol. 2006;181:57–67
  43. Sabatier N, Leng G. Presynaptic actions of endocannabinoids mediate alpha-MSH-induced inhibition of oxytocin cells. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006;290(3):R577–R584
  44. Smith SR, Terminelli C, Denhardt G. Modulation of cytokine responses in Corynebacterium parvum-primed endotoxemic mice by centrally administered cannabinoid ligands. Eur. J. Pharmacol. 2001;425(1):73–83
  45. Sofia RD, Knobloch LC, Harakal JJ, Erikson DJ. Comparative diuretic activity of delta9-tetrahydrocannabinol, cannabidiol, cannabinol and hydrochlorothiazide in the rat. Arch. Int. Pharmacodyn. Ther. 1977;225(1):77–87
  46. Steiner MA, Wotjak CT. Role of the endocannabinoid system in regulation of the hypothalamic-pituitary-adrenocortical axis. In:  Neumann ID,  Landgraf R editor. Progress in Brain Research. Elsevier. 170:UK: Oxford; 2008;p. 397–432
  47. Stern JE, Ludwig M. NO inhibits supraoptic oxytocin and vasopressin neurons via activation of GABAergic synaptic inputs. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2001;280:R1815–R1822
  48. Stern JE, Zhang W. Cellular sources, targets and actions of constitutive nitric oxide in the magnocellular neurosecretory system of the rat. J. Physiol. 2005;562:725–744
  49. Summy-Long J, Bui V, Mantz S, Koehler E, Weisz J, Kadekaro M. Central inhibition of nitric oxide synthase preferentially augments release of oxytocin during dehydration. Neurosci. Lett. 1993;152:190–193
  50. Turnbull A, Rivier C. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol. Rev. 1999;79:1–71
  51. Tyrey L, Murphy LL. Inhibition of suckling-induced milk ejections in the lactating rat by delta 9-tetrahydrocannabinol. Endocrinology. 1988;123:469–472
  52. van der Stelt M, Di Marzo V. Endovanilloids: putative endogenous ligands of transient receptor potential vanilloid 1 channels. Eur. J. Biochem. 2004;271:1827–1834
  53. Watkins LR, Maier SF, Goehler LE. Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain. 1995;63(3):289–302
  54. Watkins LR, Maier SF, Goehler LE. Cytokine-to-brain communication: a review & analysis of alternative mechanisms. Life Sci. 1995;57(11):1011–1026
  55. Weidenfeld J, Feldman S, Mechoulam R. Effect of the brain constituent anandamide, a cannabinoid receptor agonist, on the hypothalamo-pituitary-adrenal axis in the rat. Neuroendocrinology. 1994;59(2):110–112
  56. Wenger T, Moldrich G. The role of endocannabinoids in the hypothalamic regulation of visceral function. Prostaglandins Leukot. Essent. Fatty Acids. 2002;66(2–3):301–307
  57. Xia Y, Krunkoff TL. Differential neuronal activation in the hypothalamic paraventricular nucleus and autonomic/neuroendocrine responses to ICV endotoxin. Neuroscience. 2003;121:219–231
  58. Xiao M, Ding J, Wu L, Han Q, Wang H, Zuo G, et al. The distribution of neural nitric oxide synthase-positive cerebrospinal fluid-contacting neurons in the third ventricular wall of male rats and coexistence with vasopressin or oxytocin. Brain Res. 2005;1038(2):150–162

PII: S0165-5728(10)00055-X

doi: 10.1016/j.jneuroim.2010.02.006

Journal of Neuroimmunology
Volume 221, Issue 1 , Pages 32-41 , 15 April 2010

Article Tools

* Image Usage & Resolution